Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Endotoxin removal in septic shock].

Kenichi Matsuda1, Hiroyuki Hirasawa, Shigeto Oda

  • 1Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Nihon Geka Gakkai Zasshi
|February 26, 2003
PubMed
Summary

Polymyxin B-immobilized fiber (PMX-DHP) therapy showed no added benefit for septic shock patients undergoing polymethyl methacrylate continuous hemodiafiltration (PMMA-CHDF). Further investigation into PMX-DHP

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Japanese Version of 26-Item Informant Questionnaire on Cognitive Decline in the Elderly: Development and Validation Study.

Geriatrics & gerontology international·2026
Same author

High-Throughput Prediction of Protein-Protein Interactions Uncovers Hidden Molecular Networks in Biosynthetic Gene Clusters.

Computational and structural biotechnology journal·2026
Same author

A Pseudokinase Catalyzes Nitrile Formation in the Biosynthesis of a Potent Marine Toxin.

Angewandte Chemie (International ed. in English)·2026
Same author

Level-specific impairment of the 10-second grip-and-release test and grip strength in degenerative cervical myelopathy: analysis of 39 surgical cases.

BMC musculoskeletal disorders·2026
Same author

Clinical characteristics, treatments and outcomes of hospitalised COVID-19 patients across pandemic waves at a tertiary acute care hospital in Narita, Japan: a single-centre retrospective observational study.

BMJ open·2026
Same author

An atypical non-ribosomal peptide cyclase catalyzing homochiral coupling with cyclic amine nucleophile.

The Journal of antibiotics·2025

Area of Science:

  • Critical Care Medicine
  • Nephrology
  • Immunology

Background:

  • Endotoxin adsorption therapy using polymyxin B-immobilized fiber (PMX-DHP) is a recognized treatment for endotoxin-induced septic shock.
  • Recent findings suggest PMX-DHP can also remove anandamide from circulation.
  • Continuous hemodiafiltration with polymethyl methacrylate (PMMA-CHDF) is utilized to clear various humoral mediators implicated in septic shock pathogenesis.

Purpose of the Study:

  • To evaluate the additional benefit of PMX-DHP when used concurrently with PMMA-CHDF in treating septic shock patients.
  • To compare the efficacy of PMX-DHP in removing endotoxins and anandamide during PMMA-CHDF.
  • To assess the impact of combined therapies on patient survival rates.

Main Methods:

  • A comparative study involving septic shock patients undergoing PMMA-CHDF.

Related Experiment Videos

  • Inclusion of PMX-DHP as an adjunct therapy in a subset of patients.
  • Measurement of endotoxin removal rates, anandamide removal rates, and survival rates.

    • Main Results:

    • No significant difference was observed in endotoxin removal rates between patients with and without PMX-DHP during PMMA-CHDF.
    • Anandamide removal rates and overall survival rates were comparable in both treatment groups.
    • The addition of PMX-DHP did not provide additional benefits in the context of PMMA-CHDF for septic shock.

    Conclusions:

    • PMX-DHP therapy may not be necessary for septic shock patients already receiving PMMA-CHDF.
    • The indications for PMX-DHP therapy warrant re-evaluation, especially when combined with PMMA-CHDF.
    • Current evidence suggests PMMA-CHDF alone may be sufficient for managing septic shock, challenging the routine use of PMX-DHP.